Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001567619-16-002997
Filing Date
2016-09-22
Accepted
2016-09-22 16:01:30
Documents
2
Period of Report
2016-09-22
Effectiveness Date
2016-09-22

Document Format Files

Seq Description Document Type Size
1 DEF 14C h10038637x1_def14c.htm DEF 14C 154772
2 GRAPHIC logo_oncocyte.jpg GRAPHIC 63810
  Complete submission text file 0001567619-16-002997.txt   243771
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-37648 | Film No.: 161897681
SIC: 2835 In Vitro & In Vivo Diagnostic Substances